R&D Centers
Population Diagnostics Center
The Population Diagnostics Center at Łukasiewicz – PORT is the first institution of its kind in Poland. Its goal is to develop innovative diagnostic methods for infectious diseases (such as SARS-CoV-2, AH1N1, SARS) and civilization-related diseases (including cardiovascular diseases, cancer, diabetes, and obesity). It was established to strengthen the biomedical security of our society.
Scientists at the center focus on issues related to the transmission and spread of infectious diseases, host–pathogen interactions, new biological disease markers, and potential alternative therapies. They also investigate the interconnections and interactions between infectious diseases and chronic, civilization-related conditions.
The center strives for a comprehensive approach to socially significant diseases, conducting epidemiological analyses that consider relevant external factors and developing mechanisms to enable immediate action in the event of an epidemic threat.
Director of the Population Diagnostics Center: Associate Professor Patrycja Gazińska, PhD
Research Groups
Biobank Research Group
We are one of the largest centers for the collection and storage of human biological material in Poland. The Łukasiewicz – PORT Biobank collects and preserves human biological samples obtained from population studies as well as from research on specific diseases.
Bioengineering Research Group
We conduct interdisciplinary research in the fields of life sciences and nanotechnology. Our expertise includes biochemistry, chemical biology, genetic engineering, immunology, as well as selected areas of microbiology.
Epigenetic Interactions Research Group
Our group seeks to understand the protective functions of the microbiota by identifying and manipulating its mechanisms to translate this knowledge into breakthrough biotherapies that can significantly improve patients’ quality of life. We aim to combine classical microbiology and molecular biology techniques with innovative synthetic biology strategies and multi-omics approaches. This enables us to gain a deeper understanding of the functional aspects of microbiota and pathogens—from computational analyses to laboratory experiments and animal model studies—in order to uncover the true scope of these functional modifications.
Quantitative Virology Research Group
Our research focuses on molecular barcodes—molecular markers that allow for single-virus resolution studies. Combined with in silico modeling and artificial intelligence approaches, we investigate mechanistic interactions between viruses, such as HIV-1 and SARS-CoV-2, and the host genome.